Specificity of Methylation Assays in Cancer Research: A Guideline for Designing Primers and Probes
Author(s) -
Zeinab Barekati,
Ramin Radpour,
Corina Kohler,
Xiao Yan Zhong
Publication year - 2010
Publication title -
obstetrics and gynecology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.648
H-Index - 13
eISSN - 1687-9589
pISSN - 1687-9597
DOI - 10.1155/2010/870865
Subject(s) - methylation , medicine , dna methylation , epigenetics , computational biology , primer (cosmetics) , guideline , breast cancer , bioinformatics , cancer , biology , genetics , pathology , dna , gene , gene expression , chemistry , organic chemistry
DNA methylation is an epigenetic regulation mechanism of genomic function, and aberrant methylation pattern has been found to be a common event in many diseases and human cancers. A large number of cancer studies have been focused on identification of methylation changes as biomarkers (i.e., breast cancer). However, still clinical use of them is very limited because of lack of specificity and sensitivity for diagnostic test. This highlights the critical need for specific primer and probe design to avoid false-positive detection of methylation profiling. The guideline and online web tools that are introduced in this paper might help to perform a successful experiment and to develop specific diagnosis biomarkers by designing right primer pair and probe prior to experimental step.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom